EDMUND PIASECKI III: Open Payments
NPI 1477534279 · DES MOINES, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$582 in 7 payments from 6 companies in 2025. Trend: 2023 $28 · 2024 $48 · 2025 $582
Food & beverage: $471Education: $111
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 2 | $191 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $123 |
| E.R. Squibb & Sons, L.L.C. | 1 | $122 |
| Otsuka America Pharmaceutical, Inc. | 1 | $121 |
| Novo Nordisk Inc | 1 | $14 |
| Phathom Pharmaceuticals, Inc. | 1 | $11 |
Products named: CAPLYTA, COBENFY, ABILIFY MAINTENA, AUSTEDO XR, Rybelsus, VOQUEZNA.
Industry payments across IA — which companies pay providers there.
